Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

European Commission approves Stelara for moderate to severely active ulcerative colitis

Sep. 5, 2019

Twinrab approved in India for rabies

Sep. 3, 2019

FDA approves Xenleta for the treatment of community-acquired bacteria pneumonia

Aug. 20, 2019

Rozlytrek approved by FDA or two new cancer indications

Aug. 16, 2019

FDA approves new drug combination for highly drug-resistant tuberculosis

Aug. 16, 2019

FDA grants accelerated approval for bedaquiline in adolescents with MDR-TB

Aug. 13, 2019

FDA approves Turalio as first therapy for rare and debilitating joint tumor

Aug. 5, 2019

FDA approves Nubeqa for non-metastatic castration-resistant prostate cancer

July 31, 2019

FDA approves Baqsimi to treat severe hypoglycemia

July 25, 2019

FDA approves rituximab biosimilar Ruxience

July 24, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...